• BIVDA members area

Members' Press Releases

Momentum Bioscience Ltd secures CE marking for the first of its range of innovative diagnostic products

Momentum Bioscience Ltd is pleased to announce that it has CE marked Cognitor® Minus, the first in a range of products for the hospital microbiology laboratory utilising ETGA®. ETGA® is a novel technology for the rapid, universal detection of viable bacteria & fungi.

Cognitor® products are designed for the rapid detection/exclusion of infection, assisting clinicians with antibiotic stewardship, improved patient outcomes and treatment costs.

Patients at risk of sepsis are routinely placed on broad-spectrum intravenous antibiotics until definitive information is available from blood culture samples sent to the hospital laboratory. Up to 90% of blood cultures are negative but take 5 days to be confirmed as such. Cognitor® Minus gives a confirmed negative result, direct from blood culture, the day following sample receipt by the laboratory with a negative predictive value (NPV) of 99.5%.

Cognitor® Minus will have its formal launch at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) being held in Copenhagen, Denmark on 25th - 28th April 2015.

Comments are closed for this post, but if you have spotted an error or have additional info that you think should be in this post, feel free to contact us.